NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)

NCT06890273 · clinicaltrials.gov ↗
RECRUITING
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca

Collaborators